About B²O

B²O Pharmaceutical
Specialized in AI-Driven Clinical & Quantitative Pharmacology Research

B²O Pharmaceutical is an innovative pharmaceutical R&D company dedicated to artificial intelligence (AI)-driven clinical pharmacology and quantitative pharmacology. Our team consists of senior experts with global vision from multinational pharmaceutical corporations and top academic institutions, specializing in AI and quantitative pharmacology modeling. Adhering to the problem-driven R&D philosophy, we deliver professional new drug development services covering clinical pharmacology, quantitative pharmacology and artificial intelligence, fully compliant with international standards and governmental regulatory requirements.

We focus on AI-enabled clinical and quantitative pharmacology research, adopting innovative virtual drug development technologies. We have independently developed the proprietary AI-PBPK modeling software, namely the B²O Software Platform.